Imunon Statistics

Share Statistics

Imunon has 7.43M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	7.43M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	7.34M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 75.34K, so 0% of the outstanding shares have been sold short.

Short Interest	75.34K
Short % of Shares Out	n/a
Short % of Float	1.07%
Short Ratio (days to cover)	1.83

Valuation Ratios

The PE ratio is -0.74 and the forward PE ratio is null. Imunon's PEG ratio is 0.01.

PE Ratio	-0.74
Forward PE	n/a
PS Ratio	0
Forward PS	n/a
PB Ratio	3.26
P/FCF Ratio	-0.73
PEG Ratio	0.01

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Imunon.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.27.

Current Ratio	1.67
Quick Ratio	1.67
Debt / Equity	0.27
Debt / EBITDA	-0.06
Debt / FCF	-0.06
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-642.08K
Employee Count	29
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 2.26, so Imunon's price volatility has been higher than the market average.

Beta	2.26
52-Week Price Change	n/a
50-Day Moving Average	2.23
200-Day Moving Average	n/a
Relative Strength Index (RSI)	36.16
Average Volume (20 Days)	n/a

Income Statement

Revenue	n/a
Gross Profit	-718.12K
Operating Income	-19.13M
Net Income	-18.62M
EBITDA	-17.98M
EBIT	-18.7M
Earnings Per Share (EPS)	-24.27

Full Income Statement

Balance Sheet

The company has 5.87M in cash and 1.14M in debt, giving a net cash position of 4.73M.

Cash & Cash Equivalents	5.87M
Total Debt	1.14M
Net Cash	4.73M
Retained Earnings	-406.8M
Total Assets	65.33M
Working Capital	38.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.85M and capital expenditures -29.54K, giving a free cash flow of -18.88M.

Operating Cash Flow	-18.85M
Capital Expenditures	-29.54K
Free Cash Flow	-18.88M
FCF Per Share	-19.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for CLSN.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Mar 1, 2022. It was a backward split with a ratio of 1:15.

Last Split Date	Mar 1, 2022
Split Type	backward
Split Ratio	1:15

Scores

Altman Z-Score	-7.38
Piotroski F-Score	2

Imunon Inc. (CLSN)